MétaCan
Menu
Back to cohort
Record W2972612821

Vaccine strategies for prevention of community-acquired pneumonia in Canada: Who would benefit most from pneumococcal immunization?

2019· review· en· W2972612821 on OpenAlexaffabout
Alan Kaplan, Pierre Arsenault, Brian Aw, Vivien Brown, George A Fox, Ron Grossman, Taj Jadavji, Craig A. Laferrière, Suzanne Levitz, Mark Loeb, Andrew McIvor, Christopher H. Mody, Yannick Poulin, Marla Shapiro, Dominique Tessier, Francois Théorêt, Karl Heinz Weiss, John Yaremko, George G. Zhanel

Bibliographic record

VenuePubMed · 2019
Typereview
Languageen
FieldMedicine
TopicPneumonia and Respiratory Infections
Canadian institutionsUniversity of ManitobaJewish General HospitalCégep de l'OutaouaisHôpital Saint-LucMcGill UniversityMcGill University Health CentreMcMaster UniversityPfizer (Canada)Memorial University of NewfoundlandCollege of Family Physicians of CanadaUniversity of CalgaryUniversité de SherbrookeUniversity of Toronto
Fundersnot available
KeywordsMedicineVaccinationPneumococcal polysaccharide vaccinePneumococcal conjugate vaccinePneumococcal pneumoniaImmunizationPneumococcal diseasePneumococcal vaccinePneumoniaAdvisory committeePopulationCommunity-acquired pneumoniaPneumococcal infectionsPediatricsImmunologyFamily medicineStreptococcus pneumoniaeEnvironmental healthInternal medicineAntibioticsAntigen
DOInot available

Abstract

fetched live from OpenAlex

OBJECTIVE: To describe the burden of pneumococcal disease and associated risk factors in the Canadian adult population, delineate available pneumococcal vaccines and associated efficacy and effectiveness data, and review current pneumococcal vaccine recommendations and community-acquired pneumonia (CAP) prevention strategies in Canada. QUALITY OF EVIDENCE: Pneumococcal vaccination guidelines from the Canadian National Advisory Committee on Immunization in 2013 and 2016 constitute level III evidence for CAP prevention in the Canadian adult population. MAIN MESSAGE: It is recommended that immunosuppressed adults of all ages receive the 13-valent pneumococcal conjugate vaccine (PCV13) (grades A and B recommendations). In 2016, the National Advisory Committee on Immunization also recommended that all adults aged 65 years and older receive PCV13 (grade A recommendation) on an individual basis, followed by the 23-valent pneumococcal polysaccharide vaccine (grade B recommendation). This update is based on a large clinical study that demonstrated PCV13 efficacy against vaccine-type CAP in this population. CONCLUSION: Physicians should focus on improving pneumococcal vaccination rates among adults, which remain low. Vaccination with PCV13 should also be considered for adults with chronic conditions, whose baseline risk is often higher than that for healthy individuals aged 65 years and older.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.006
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Systematic review · Consensus signal: none
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.620
Threshold uncertainty score0.755

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0020.006
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0030.002
Bibliometrics0.0040.004
Science and technology studies0.0010.001
Scholarly communication0.0020.001
Open science0.0010.001
Research integrity0.0020.002
Insufficient payload (model declined to judge)0.0060.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.076
GPT teacher head0.316
Teacher spread0.239 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designSystematic review
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations8
Published2019
Admission routes2
Has abstractyes

Explore more

Same venuePubMedSame topicPneumonia and Respiratory InfectionsFrench-language works237,207